- Home
- OMEX vs ALGS Comparison
OMEX vs ALGS Comparison
Compare OMEX & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMEX | ALGS |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | United States | United States |
| Employees | 11 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 40.6M |
| IPO Year | 2024 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OMEX | ALGS |
|---|---|---|
| Price | $0.95 | $8.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | ★ 1.0M | 35.0K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | $9,327.00 | ★ $2,186,000.00 |
| Revenue This Year | N/A | $4.99 |
| Revenue Next Year | N/A | $8.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.28 | $3.76 |
| 52 Week High | $4.43 | $13.69 |
Technical Indicators
Market Signals| Indicator | OMEX | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 62.29 |
| Support Level | N/A | $6.21 |
| Resistance Level | $1.75 | $8.30 |
| Average True Range (ATR) | 0.15 | 0.56 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 25.89 | 80.00 |
Price Performance
Historical ComparisonAbout OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.